AdvisorNet Financial Inc Has $1.87 Million Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

AdvisorNet Financial Inc boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,040 shares of the company’s stock after acquiring an additional 2,080 shares during the quarter. AdvisorNet Financial Inc’s holdings in GE HealthCare Technologies were worth $1,873,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Sky Investment Group LLC lifted its holdings in shares of GE HealthCare Technologies by 3.3% in the second quarter. Sky Investment Group LLC now owns 51,932 shares of the company’s stock valued at $4,047,000 after purchasing an additional 1,675 shares in the last quarter. GPS Wealth Strategies Group LLC boosted its holdings in shares of GE HealthCare Technologies by 74.3% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 1,715 shares of the company’s stock valued at $134,000 after buying an additional 731 shares during the last quarter. ORG Partners LLC increased its holdings in GE HealthCare Technologies by 2,475.0% during the second quarter. ORG Partners LLC now owns 412 shares of the company’s stock worth $32,000 after buying an additional 396 shares during the last quarter. V Square Quantitative Management LLC raised its position in GE HealthCare Technologies by 102.7% during the second quarter. V Square Quantitative Management LLC now owns 9,239 shares of the company’s stock worth $720,000 after acquiring an additional 4,681 shares in the last quarter. Finally, Community Bank of Raymore grew its position in shares of GE HealthCare Technologies by 16.4% in the 2nd quarter. Community Bank of Raymore now owns 13,363 shares of the company’s stock valued at $1,041,000 after acquiring an additional 1,880 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Up 2.3 %

Shares of GEHC traded up $1.93 during trading hours on Thursday, reaching $85.40. 1,040,431 shares of the company traded hands, compared to its average volume of 3,074,003. The stock’s fifty day moving average price is $79.57 and its 200 day moving average price is $82.93. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.05. The firm has a market cap of $38.98 billion, a price-to-earnings ratio of 24.95, a PEG ratio of 3.00 and a beta of 1.17. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The company had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same period last year, the company posted $0.92 earnings per share. GE HealthCare Technologies’s revenue was up .5% compared to the same quarter last year. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend is Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

Analysts Set New Price Targets

Several equities analysts recently commented on GEHC shares. Stifel Nicolaus started coverage on shares of GE HealthCare Technologies in a research note on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price target on the stock. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Mizuho cut their target price on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research report on Wednesday, May 1st. The Goldman Sachs Group initiated coverage on GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price objective on the stock. Finally, Bank of America reduced their price target on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 1st. Five investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $94.58.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the firm’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, CTO Taha Kass-Hout sold 3,300 shares of the firm’s stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total value of $259,710.00. Following the sale, the chief technology officer now directly owns 67,300 shares of the company’s stock, valued at $5,296,510. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the transaction, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. The disclosure for this sale can be found here. 0.27% of the stock is owned by corporate insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.